Skip to main navigation Skip to search Skip to main content

Weekly: Y-mAbs Therapeutics (YMAB: $6.25) falls 5.0% on low volume; -33c [5.0%]

Press/Media: Research

PeriodJul 31 2023

Media coverage

1

Media coverage